Biological aging and in the person and the animal regenerative capacity, carcinogenic risk, the age increase characteristic disease the marker in order to measure, the DNA damage and teromea dysfunction in order to measure the convalescence of risk and the chronic disease which emerge

摘要

As for this invention, as for the aforementioned method, process below, namely, the fact that at least the quantity or activity of the protein marker of 1 types in blood or serum sample is measured is included the DNA damage and in regard to the method in order the existence of teromea dysfunction and to measure in the person and the animal, the aforementioned protein is selected from the group which consists of EF1 , kitobioshidaze, sutasumin and CRAMP.